Cost-utility and budget impact analysis of adding-on apremilast to biologic therapy in the treatment of moderate to severe plaque psoriasis, an Iranian payer perspective
-
Published:2021
Issue:4
Volume:16
Page:381
-
ISSN:1735-5362
-
Container-title:Research in Pharmaceutical Sciences
-
language:en
-
Short-container-title:Res Pharma Sci
Author:
Zargaran Marzieh,Soleymani Fatemeh,Nasrollahi SamanAhmad,Seyedifar Meysam,Rahaghi MohammadMehdi Ashrafian
Subject
General Pharmacology, Toxicology and Pharmaceutics